Diversified Pipeline – Increased Probability of Commercial Success
We have developed a pipeline of novel medicines against our genetically derived targets. As part of maintaining a balanced and broader pipeline, we have both non-partnered and partnered products in development.
| Program | Discovery | Pre-clinical | Phase 1 | Phase 2 | Phase 3 | Partners | |||||||
| Pain |
Oral XEN402
|
![]() |
|||||||||||
| Pain |
Topical XEN402
|
||||||||||||
| Pain |
Oral XEN403
|
||||||||||||
| Pain | |||||||||||||
| Anemia |
XEN701
|
||||||||||||
| Cardiovascular | |||||||||||||
| Metabolic | |||||||||||||




